Treatment of pharyngeal non-Hodgkin lymphoma in a patient with Wiskott-Aldrich syndrome

Paola Coccia, Stefano Mastrangelo, Antonio Ruggiero, Maria Scalzone, Angelo Rosolen, Palma Maurizi, Riccardo Riccardi

Risultato della ricerca: Contributo in rivistaArticolo in rivista

8 Citazioni (Scopus)


Wiskott-Aldrich syndrome (WAS) is characterized by primary immunodeficiency, thrombocytopenia and eczema. Patients with WAS have an increased risk to develop tumors. Non-Hodgkin lymphoma (NHL) represents the most common malignancy occurring in WAS-affected patients, diffuse-large-B-cell lymphoma is the most frequently encountered variant. We describe a case of a patient with WAS and NHL in the pharynx, an atypical tumor site presentation. The patient was successfully treated with a reduced dose chemotherapy regimen plus anti-CD20 monoclonal antibody. He is in complete remission 3 years from the start of treatment. Pediatr Blood Cancer 2012;59:318-319. © 2011 Wiley Periodicals, Inc.
Lingua originaleEnglish
pagine (da-a)318-319
Numero di pagine2
Stato di pubblicazionePubblicato - 2012


  • Wiscott-Aldrich syndrome
  • pharyngeal non Hodgkin Lymphoma


Entra nei temi di ricerca di 'Treatment of pharyngeal non-Hodgkin lymphoma in a patient with Wiskott-Aldrich syndrome'. Insieme formano una fingerprint unica.

Cita questo